Switching to bictegravir/emtricitabine/tenofovir alafenamide in Black Americans with HIV-1: A randomized phase 3b, multicenter, open-label study
Journal of Acquired Immune Deficiency Syndromes | Aug 24, 2021
Journal of Acquired Immune Deficiency Syndromes | Aug 24, 2021